Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
JNJ

Johnson & Johnson

$147.18

0.66 (0.45%)

17:09
12/12/18
12/12
17:09
12/12/18
17:09
Periodicals
J&J said to be ready to pay more than $400M to settle hip cases, Bloomberg says »

Johnson & Johnson is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

JNJ

Johnson & Johnson

$148.01

1.49 (1.02%)

15:13
12/12/18
12/12
15:13
12/12/18
15:13
Periodicals
Breaking Periodicals news story on Johnson & Johnson »

J&J said to be ready…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

JNJ

Johnson & Johnson

$147.43

0.91 (0.62%)

11:45
12/12/18
12/12
11:45
12/12/18
11:45
Conference/Events
Johnson & Johnson management to meet with Oppenheimer »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

MNK

Mallinckrodt

$21.11

0.16 (0.76%)

, ENDP

Endo

$11.45

0.23 (2.05%)

10:38
12/12/18
12/12
10:38
12/12/18
10:38
On The Fly
Mallinckrodt rises despite FDA failing to approve opioid painkiller »

Shares of Mallinckrodt…

MNK

Mallinckrodt

$21.11

0.16 (0.76%)

ENDP

Endo

$11.45

0.23 (2.05%)

JNJ

Johnson & Johnson

$148.10

1.58 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

MRK

Merck

$78.11

0.99 (1.28%)

10:33
12/12/18
12/12
10:33
12/12/18
10:33
Hot Stocks
Merck, Instituto Butantan collaborate to develop vaccines for dengue infections »

Merck and Instituto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

  • 16

    Feb

AAPL

Apple

$170.80

2.14 (1.27%)

, INTC

Intel

$47.85

0.47 (0.99%)

10:19
12/12/18
12/12
10:19
12/12/18
10:19
Periodicals
Apple developing cellular modem chip, The Information reports »

In a job listing posted a…

AAPL

Apple

$170.80

2.14 (1.27%)

INTC

Intel

$47.85

0.47 (0.99%)

QCOM

Qualcomm

$58.10

0.76 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNBT

Generex

$0.00

(0.00%)

, MRK

Merck

$77.90

0.78 (1.01%)

10:07
12/12/18
12/12
10:07
12/12/18
10:07
Hot Stocks
Generex receives IND approval from FDA for Phase II combination study »

Generex Biotechnology…

GNBT

Generex

$0.00

(0.00%)

MRK

Merck

$77.90

0.78 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

  • 16

    Feb

EMR

Emerson

$61.73

-0.57 (-0.91%)

10:01
12/12/18
12/12
10:01
12/12/18
10:01
Hot Stocks
Emerson acquires Advanced Engineering Valves, terms not disclosed »

Emerson announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$148.20

1.68 (1.15%)

09:55
12/12/18
12/12
09:55
12/12/18
09:55
Hot Stocks
Janssen says Phase 3 data demonstrate superiority of Tremfya vs. Consentyx »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

QCOM

Qualcomm

$57.34

(0.00%)

, AAPL

Apple

$168.66

(0.00%)

09:43
12/12/18
12/12
09:43
12/12/18
09:43
Periodicals
Qualcomm says Apple is breaching court order with iPhone sales, CNBC reports »

Qualcomm (QCOM) has said…

QCOM

Qualcomm

$57.34

(0.00%)

AAPL

Apple

$168.66

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.